Augmedix, Inc.
AUGX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 45% | 39.6% | 34.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 48% | 45.1% | 45.1% | 41.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -34.9% | -70.5% | -65.3% | -80.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -42.7% | -85.8% | -77.4% | -89.4% |
| EPS Diluted | -0.44 | -0.71 | -0.59 | -0.55 |
| % Growth | 38% | -20.3% | -7.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |